United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 284,258 | 154,030 | 162,676 | 252,162 | 100,352 |
| Marketable Securities | 409,645 | 325,175 | 240,803 | 374,921 | 129,140 |
| Receivables | 126,297 | 116,626 | 88,680 | 73,707 | 50,626 |
| Inventories | 47,758 | 37,254 | 45,981 | 35,520 | 26,360 |
| Income taxes - deferred | N/A | N/A | 8,199 | 12,585 | 7,192 |
| Other current assets | 46,424 | 35,385 | 6,188 | 6,840 | 2,638 |
| TOTAL | $914,382 | $668,470 | $562,455 | $764,487 | $324,507 |
| Non-Current Assets | |||||
| PPE Net | 464,950 | 453,685 | 366,046 | 306,044 | 303,859 |
| Investments And Advances | 448,134 | 311,103 | 349,022 | 137,971 | 188,604 |
| Other Non-Current Assets | 260,101 | 193,337 | 240,556 | 223,133 | 234,574 |
| TOTAL | $1,173,185 | $958,125 | $955,624 | $667,148 | $727,037 |
| Total Assets | $2,087,567 | $1,626,595 | $1,518,079 | $1,431,635 | $1,051,544 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 282,459 | 1,291 | N/A | 235,968 | 220,272 |
| Accounts payable and accrued liabilities | 92,244 | 10,203 | 47,257 | 16,146 | 18,750 |
| Accrued Expenses | N/A | 72,985 | 57,227 | 50,280 | 29,764 |
| Other current liabilities | 312,971 | 92,276 | 108,093 | 126,292 | 61,401 |
| TOTAL | $687,674 | $176,755 | $212,577 | $428,686 | $330,187 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 70,343 | 71,452 | 68,929 | N/A |
| aiOther Non-Current Liabilities | 140,619 | 295,516 | 285,562 | 50,134 | 38,021 |
| TOTAL | $140,619 | $365,859 | $357,014 | $119,063 | $68,348 |
| Total Liabilities | $828,293 | $542,614 | $569,591 | $547,749 | $398,535 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,477 | 50,183 | 53,627 | 57,754 | 54,608 |
| Common Shares | 630 | 621 | 615 | 600 | 567 |
| Retained earnings | 728,040 | 553,480 | 249,038 | 31,170 | -74,746 |
| Other shareholders' equity | -13,620 | -14,955 | -10,883 | -9,574 | -4,709 |
| TOTAL | $1,259,274 | $1,083,981 | $948,488 | $883,886 | $653,009 |
| Total Liabilities And Equity | $2,087,567 | $1,626,595 | $1,518,079 | $1,431,635 | $1,051,544 |